CAJ | 학술논문

卵巢癌是妇科三大常见的恶性肿瘤之一，病死率高居首位，关于卵巢癌的临床研究一直是近几年国际肿瘤研究的热点。目前，卵巢癌的诊治主要参考 NCCN 制订的《卵巢癌临床实践指南》，该指南已有2012年第二版的更新。本文主要对近两年国际和国内在卵巢癌的手术治疗、新辅助化疗、化疗用药和遗传突变的作用等几个方面的相关临床研究及未来的发展趋势作一综述。
란소암시부과삼대상견적악성종류지일，병사솔고거수위，관우란소암적림상연구일직시근궤년국제종류연구적열점。목전，란소암적진치주요삼고 NCCN 제정적《란소암림상실천지남》，해지남이유2012년제이판적경신。본문주요대근량년국제화국내재란소암적수술치료、신보조화료、화료용약화유전돌변적작용등궤개방면적상관림상연구급미래적발전추세작일종술。
Ovarian cancer was one of the three most common malignant tumors in gynecology department. Its fatality rate ranked first and it has become the hot spot in the international cancer research in recent years. At present, the NCCN clinical practice guidelines for ovarian cancer are primarily consulted in the diagnosis and treatment of ovarian cancer. This guideline has been updated in 2012. In this paper we mainly summarized the international and domestic clinical researches on about ovarian cancer in aspects of surgical treatment, neoadjuvant chemotherapy, chemotherapy drugs and the role of genetic mutations in last two years, as well as the development trend.